Literature DB >> 26966180

Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A).

Hisayo Nishida-Fukuda1, Ryoichi Araki2, Masachika Shudou3, Hidenori Okazaki2, Yasuko Tomono4, Hironao Nakayama5, Shinji Fukuda6, Tomohisa Sakaue6, Yuji Shirakata2, Koji Sayama2, Koji Hashimoto2, Michael Detmar7, Shigeki Higashiyama5, Satoshi Hirakawa8.   

Abstract

Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), a type I transmembrane glycoprotein, is known as one of the most specific lymphatic vessel markers in the skin. In this study, we found that the ectodomain of LYVE-1 undergoes proteolytic cleavage, and this process produces soluble LYVE-1. We further identified the cleavage site for ectodomain shedding and generated an uncleavable mutant of LYVE-1. In lymphatic endothelial cells, ectodomain shedding of LYVE-1 was induced by vascular endothelial growth factor (VEGF)-A, an important factor for angiogenesis and lymphangiogenesis under pathological conditions. VEGF-A-induced LYVE-1 ectodomain shedding was mediated via the extracellular signal-regulated kinase (ERK) and a disintegrin and metalloproteinase (ADAM) 17. Wild-type LYVE-1, but not uncleavable LYVE-1, promoted migration of lymphatic endothelial cells in response to VEGF-A. Immunostaining analyses in human psoriasis skin lesions and VEGF-A transgenic mouse skin suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ADAM; endothelial cell; extracellular signal-regulated kinase (ERK); hyaluronan; lymphangiogenesis; lymphatic endothelial hyaluronan receptor 1 (LYVE-1); psoriasis; shedding; skin; vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2016        PMID: 26966180      PMCID: PMC4865900          DOI: 10.1074/jbc.M115.683201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors.

Authors:  Isamu Okamoto; Hiromasa Tsuiki; Lawrence C Kenyon; Andrew K Godwin; David R Emlet; Marina Holgado-Madruga; Irene S Lanham; Christopher J Joynes; Kim T Vo; Abhijit Guha; Mitsuhiro Matsumoto; Yukitaka Ushio; Hideyuki Saya; Albert J Wong
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.

Authors:  Marika J Karkkainen; Paula Haiko; Kirsi Sainio; Juha Partanen; Jussi Taipale; Tatiana V Petrova; Michael Jeltsch; David G Jackson; Marja Talikka; Heikki Rauvala; Christer Betsholtz; Kari Alitalo
Journal:  Nat Immunol       Date:  2003-11-23       Impact factor: 25.606

3.  Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.

Authors:  Satoshi Hirakawa; Young-Kwon Hong; Natasha Harvey; Vivien Schacht; Kant Matsuda; Towia Libermann; Michael Detmar
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

4.  Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.

Authors:  Hiroyuki Nakamura; Naoko Suenaga; Kaori Taniwaki; Hirokazu Matsuki; Kayoko Yonezawa; Masato Fujii; Yasunori Okada; Motoharu Seiki
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

5.  Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.

Authors:  Natalia Platonova; Geraldine Miquel; Birgit Regenfuss; Said Taouji; Claus Cursiefen; Eric Chevet; Andreas Bikfalvi
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

6.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice.

Authors:  M Detmar; L F Brown; M P Schön; B M Elicker; P Velasco; L Richard; D Fukumura; W Monsky; K P Claffey; R K Jain
Journal:  J Invest Dermatol       Date:  1998-07       Impact factor: 8.551

7.  Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis.

Authors:  Janice A Nagy; Eliza Vasile; Dian Feng; Christian Sundberg; Lawrence F Brown; Michael J Detmar; Joel A Lawitts; Laura Benjamin; Xiaolian Tan; Eleanor J Manseau; Ann M Dvorak; Harold F Dvorak
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

8.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

9.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

Authors:  M Detmar; L F Brown; K P Claffey; K T Yeo; O Kocher; R W Jackman; B Berse; H F Dvorak
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

10.  Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation.

Authors:  Osamu Nagano; Daizo Murakami; Dieter Hartmann; Bart De Strooper; Paul Saftig; Takeshi Iwatsubo; Motowo Nakajima; Masanori Shinohara; Hideyuki Saya
Journal:  J Cell Biol       Date:  2004-06-14       Impact factor: 10.539

View more
  16 in total

1.  Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes.

Authors:  Hyosuk Cho; Gong-Qing Shen; Xiaofeng Wang; Fan Wang; Stephen Archacki; Yabo Li; Gang Yu; Susmita Chakrabarti; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Biol Chem       Date:  2019-01-17       Impact factor: 5.157

2.  Finding New Ways How to Control BACE1.

Authors:  Jarmila Nahálková
Journal:  J Membr Biol       Date:  2022-03-19       Impact factor: 1.843

Review 3.  Formation and Growth of Cardiac Lymphatics during Embryonic Development, Heart Regeneration, and Disease.

Authors:  Dana Gancz; Gal Perlmoter; Karina Yaniv
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-06-01       Impact factor: 9.708

4.  Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.

Authors:  Suneale Banerji; William Lawrance; Clive Metcalfe; David C Briggs; Akira Yamauchi; Omer Dushek; P Anton van der Merwe; Anthony J Day; David G Jackson
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

Review 5.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

6.  An immune response to the avascular lens following wounding of the cornea involves ciliary zonule fibrils.

Authors:  JodiRae DeDreu; Caitlin J Bowen; Caitlin M Logan; Sonali Pal-Ghosh; Paola Parlanti; Mary Ann Stepp; A Sue Menko
Journal:  FASEB J       Date:  2020-05-25       Impact factor: 5.191

7.  Co-transplantation with adipose-derived cells to improve parathyroid transplantation in a mice model.

Authors:  Qiuxia Cui; Dan Zhang; Deguang Kong; Jianing Tang; Xing Liao; Qian Yang; Jiangbo Ren; Yan Gong; Gaosong Wu
Journal:  Stem Cell Res Ther       Date:  2020-05-26       Impact factor: 6.832

8.  Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.

Authors:  Yuta Hara; Ryota Torii; Shiho Ueda; Erina Kurimoto; Eri Ueda; Hiroshi Okura; Yutaka Tatano; Hideki Yagi; Yoshiya Ohno; Toshiyuki Tanaka; Kazue Masuko; Takashi Masuko
Journal:  Cancer Sci       Date:  2018-08-26       Impact factor: 6.716

9.  The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation.

Authors:  Claudia Dollt; Kathrin Becker; Julia Michel; Susanne Melchers; Cleo-Aron Weis; Kai Schledzewski; Andreas Krewer; Loreen Kloss; Christoffer Gebhardt; Jochen Utikal; Astrid Schmieder
Journal:  Oncotarget       Date:  2017-10-10

10.  Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.

Authors:  Jia Wang; Yanhong Ma; Jingshi Yang; Lu Jin; Zixiang Gao; Lingyun Xue; Lin Hou; Linlin Sui; Jing Liu; Xiangyang Zou
Journal:  J Cell Mol Med       Date:  2019-01-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.